Emmecell
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3475 Edison Way Ste T, Menlo Park, Calif...Website
www.emmecell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Emmecell
Emmecell is a clinical-stage biotechnology company specializing in the development of cell-based therapies for eye diseases through its innovative Magnetic Cell Delivery (MCD) nanoparticle platform. The company addresses challenges in the localization and integration of cell therapies, aiming to enhance regenerative medicine applications. Emmecell also operates CellMP, a subsidiary that offers research, process development, and cGMP manufacturing services to support biotechnology companies and startups. Their primary focus is on ophthalmic indications, with a commitment to advancing patient care through cutting-edge technology.Explore more
Emmecell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emmecell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Emmecell is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Emmecell
Product Launch: Get notified when Emmecell launches new products
Funding: Get notified immidiatlly once Emmecell has new funding data
Click to see if Emmecell had a recent Job posting/layoffs
Emmecell, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Emmecell has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Emmecell recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Emmecell
Compare insights from companies similar to Emmecell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Emmecell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Emmecell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Emmecell.
Emmecell Tech Stack
A closer look at the technologies used by Emmecell
Emmecell News & Media
Emmecell Completes Last Patient Last Visit for Proof-of-Concept Trial of Groundbreaking Cell Therapy for Corneal Edema
MENLO PARK, Calif., Oct. 8, 2024 /PRNewswire/ -- Emmetrope Ophthalmics, LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for the treatment of serious eye diseases, today announced the successful completion of the...Emmecell Announces First Patient Dosed with EO2002 in US Phase 1 Study...
First in class novel magnetic cell-based therapy to address disease without surgery (PRWeb July 21, 2021) Read the full story at https://www.prweb.com/releases/emmecell_announces_first_patient_dosed_with_eo2002_in_us_phase_1_study_in_patients_with_corneal_edema/prweb18079085.htm
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emmecell
Sign Up For FreeTo access detailed company insights
Emmecell is a clinical-stage biotechnology company specializing in the development of cell-based therapies for eye diseases through its innovative Magnetic Cell Delivery (MCD) nanoparticle platform. The company addresses challenges in the localization and integration of cell therapies, aiming to enhance regenerative medicine applications. Emmecell... Read More
